Frontline: Surgery to remove the tumor is often considered, sometimes followed by chemotherapy or radiation to reduce ...
The Neotorch randomized phase III clinical trial was designed to evaluate whether the addition of perioperative toripalimab [programmed cell death 1 (PD-1) inhibitor] to platinum-based chemotherapy ...
Chemotherapy’s gut damage turns out to have a surprising upside. By changing nutrient availability in the intestine, it ...
Genetic Counseling, Testing, and Family Communication Into Survivorship After Diagnosis of Breast Cancer Patients with GCT who received TIP after cisplatin-based chemotherapy were eligible. Favorable ...
The randomized phase III AALL1731 trial presented at the American Society of Hematology annual meeting showed that adding the bispecific T-cell engager blinatumomab (Blincyto) to chemotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results